Skip to main content
OpenTrials
Completed

NCT Number: NCT05774236

Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction

The goal of this clinical trial is to compare how two methods for cervical ripening work in a population of singleton pregnancies with late-onset fetal growth restriction (FGR) at term.

The main question it aims to answer is whether Cook´s balloon (a mechanical method) is superior to vaginal dinoprostone (a pharmacological method) in achieving a vaginal delivery.

Participants will be randomized to receive Cook´s balloon (experimental group) or vaginal dinoprostone (control group) for cervical ripening.

Researchers will compare both groups to see if Cook´s balloon is associated with a higher rate of vaginal delivery than vaginal dinoprostone. Neonatal outcomes (including neonatal acidosis, the MAIN morbidity score, and NICU admission) will be assessed as secondary, descriptive endpoints.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Hospital Clinic i Provincial, Barcelona, Spain

Loading trial locations.

About this study

Late-onset fetal growth restriction (FGR) represents the most common subtype of FGR (70-80%). The greatest risk for these fetuses appears once term pregnancy is reached, when stressful situations are added to their status of relative hypoxia, such as the appearance of contractions and funicular compression. Thus, it has been shown that from week 37-38 the risk of intrauterine mortality increases and there is a general consensus not to prolong these pregnancies beyond this period. In this situation, induction of labor is usually preferred over elective caesarean delivery. However, these fetuses have an increased risk of cesarean section for suspected fetal distress.

Mechanical methods for cervical ripening are associated with less uterine stimulation with a lower rate of tachysystole than prostaglandins. Therefore, these methods have been proposed as the optimal approach for late-onset FGR, since they could reduce the rate of cesarean sections for suspected fetal distress. However, there is no published randomized controlled trials on the use of different methods of cervical ripening for labor induction in late-onset FGR.

Thus, the investigators postulate that, in late-onset FGR, cervical ripening with a mechanical method (Cook´s balloon) achieves a higher percentage of vaginal deliveries than a pharmacological method (vaginal dinoprostone), being safe for both the mother and the newborn.

The main aim of this study is to evaluate whether cervical ripening with Cook balloon for labor induction at term gestation of singleton pregnancies with late-onset FGR achieves a higher rate of vaginal delivery compared to the use of vaginal dinoprostone. Neonatal safety outcomes (neonatal acidosis, the MAIN morbidity score, and NICU admission) will be analyzed as secondary endpoints, in a descriptive manner.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Singleton pregnancy
  • Age ≥ 18 years
  • Gestational age (GA) dated by first trimester ultrasound ≥ 37+0 weeks
  • Cephalic presentation
  • Stage I fetal growth restriction, defined as the presence of at least one of these two criteria:
  • Estimated fetal weight (EFW) < 3rd percentile
  • EFW < 10th percentile and at least one of the following: 2.1) Umbilical artery pulsatility index > 95th percentile or 2.2) Cerebral-placental index < 5th percentile
  • Bishop score < 7
  • Intact fetal membranes
  • No previous caesarean section
  • No contraindications for vaginal delivery or labor induction.

Exclusion criteria

  • Major fetal malformation
  • Fetal genetic abnormality
  • Fetal congenital infection

Treatment and study plan

Cook´s balloon

Device

Cervical ripening for induction of labor with a mechanical method (Cook´s balloon)

Other names: Cook® Cervical Ripening Balloon with Stylet, Double balloon catheter

Vaginal Dinoprostone

Drug

Cervical ripening for induction of labor with a pharmacological method (vaginal dinoprostone)

Other names: Dinoprostone vaginal insert, Controlled-release dinoprostone delivery system, Vaginal prostaglandin E2

Primary outcomes

  1. Rate of vaginal delivery

    Time frame: 2 days (from admission to delivery)

    To assess whether cervical ripening with a Cook balloon for induction of labor of term pregnancies with FGR increases the rates of vaginal delivery with respect to the use of vaginal dinoprostone.

Secondary outcomes

  1. Rate of cesarean sections due to suspected fetal distress

    Time frame: 2 days (from admission to delivery)

    To assess whether cervical ripening with a Cook balloon for induction of labor of term pregnancies with FGR decreases the rates of cesarean sections due to suspected fetal distress with respect to the use of vaginal dinoprostone

  2. Induction-to-delivery interval

    Time frame: 2 days (from admission to delivery)

    Comparison of the time interval between the onset of cervical ripening and delivery between the two arms

  3. Neonatal morbidity

    Time frame: From delivery to discharge of the newborn (up to 1 month)

    To analyze the neonatal morbidity through the MAIN score (Morbidity assessment index for newborns) of neonatal morbidity and the duration of admissions to the Neonatal Intensive Care Unit (NICU).

Sponsors and collaborators

Lead sponsor

Hospital Universitario 12 de Octubre

Other

Collaborators

  • Instituto de Salud Carlos III
  • Spanish Clinical Research Network - SCReN

Registry information

Official study title

Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction (COLIGROW)

Acronym: COLIGROW

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Mar 17, 2023
Registry last updated
Jul 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.